| Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo [1, 2-c][1, 2, 3] thiadiazole-7-sulphonamides L Baranauskienė, M Hilvo, J Matulienė, D Golovenko, E Manakova, ... Journal of enzyme inhibition and medicinal chemistry 25 (6), 863-870, 2010 | 75 | 2010 |
| Structural mechanisms for the 5′-CCWGG sequence recognition by the N-and C-terminal domains of EcoRII D Golovenko, E Manakova, G Tamulaitiene, S Grazulis, V Siksnys Nucleic acids research 37 (19), 6613-6624, 2009 | 45 | 2009 |
| New insights into the role of DNA shape on its recognition by p53 proteins D Golovenko, B Bräuning, P Vyas, TE Haran, H Rozenberg, Z Shakked Structure 26 (9), 1237-1250. e6, 2018 | 42 | 2018 |
| Diverse p53/DNA binding modes expand the repertoire of p53 response elements P Vyas, I Beno, Z Xi, Y Stein, D Golovenko, N Kessler, V Rotter, ... Proceedings of the National Academy of Sciences 114 (40), 10624-10629, 2017 | 39 | 2017 |
| 4-[N-(Substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII J Sūdžius, L Baranauskienė, D Golovenko, J Matulienė, V Michailovienė, ... Bioorganic & medicinal chemistry 18 (21), 7413-7421, 2010 | 38 | 2010 |
| Indapamide-like benzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, and XIII E Čapkauskaitė, L Baranauskienė, D Golovenko, E Manakova, S Gražulis, ... Bioorganic & medicinal chemistry 18 (21), 7357-7364, 2010 | 38 | 2010 |
| Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ) O Degtjarik, D Golovenko, Y Diskin-Posner, L Abrahmsén, H Rozenberg, ... Nature communications 12 (1), 7057, 2021 | 37 | 2021 |
| Structural insight into the specificity of the B3 DNA-binding domains provided by the co-crystal structure of the C-terminal fragment of BfiI restriction enzyme D Golovenko, E Manakova, L Zakrys, M Zaremba, G Sasnauskas, ... Nucleic acids research 42 (6), 4113-4122, 2014 | 29 | 2014 |
| Structural basis of microRNA biogenesis by Dicer-1 and its partner protein Loqs-PB K Jouravleva, D Golovenko, G Demo, RC Dutcher, TMT Hall, PD Zamore, ... Molecular cell 82 (21), 4049-4063. e6, 2022 | 25 | 2022 |
| The complex architecture of p53 binding sites A Senitzki, J Safieh, V Sharma, D Golovenko, Y Danin-Poleg, A Inga, ... Nucleic Acids Research 49 (3), 1364-1382, 2021 | 17 | 2021 |
| Structural mechanisms of the degenerate sequence recognition by Bse634I restriction endonuclease E Manakova, S Gražulis, M Zaremba, G Tamulaitiene, D Golovenko, ... Nucleic acids research 40 (14), 6741-6751, 2012 | 6 | 2012 |
| Crystal structure of restriction endonuclease Kpn2I of CCGG-family E Manakova, M Mikutenaite, D Golovenko, S Gražulis, G Tamulaitiene Biochimica et Biophysica Acta (BBA)-General Subjects 1865 (8), 129926, 2021 | | 2021 |
| How the tumor suppressor p53 recognizes its DNA response elements D Golovenko, O Degtjarik, TE Haran, H Rozenberg, Z Shakked JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS 37, 38-39, 2019 | | 2019 |
| Structural studies on reactivation of tumor-related p53 mutants by methylene quinuclidinone (MQ), the active drug spontaneously formed from APR-246 O Degtjarik, D Golovenko, Y Diskin-Posner, L Abrahmsen, H Rozenberg, ... JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS 37, 39-40, 2019 | | 2019 |
| Hemi-specific binding by p53 expands the universe of p53 targets P Vyas, I Beno, Z Xi, N Kessler, D Golovenko, Z Shakked, TE Haran 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on …, 2017 | | 2017 |
Saulius GrazulisSenior research fellow, Vilnius University, Life Sciences Center, Institute of BiotechnologyE-mail confirmado em ibt.lt
